NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Bionema Group Limited

Bionema Group Limited

Private
SwanseaHealthcare & Life Scienceshttps://bionema.com/

Last Round

Grant

Sep 18, 2025

Total Funding Raised

$3.03M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Bionema Group Limited is an agtech company that develops nature-based solutions for crop protection and plant health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

biopesticidesbiocontrolentomopathogenic nematodesbiologicalsbiostimulantsagritechagtechbiofertiliserssustainable agriculturecrop protectionmicro-encapsulation technologyagricultural biotechnologysoil healthcontract researchsports turf management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bionema Group Limited Comparables

Compare Bionema Group Limited with similar companies based on industry and business-model similarity.

Bionema Group Limited comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
e-nema GmbH
88%
PromoSEED Biyoteknoloji
79%
Pheronym
78%

Bionema Group Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 18, 2025
Series AJul 7, 2025
GrantDec 31, 2019
SeedApr 26, 2019
SeedJul 9, 2018

Key People

Founding team and executive leadership

Minshad Ali Ansari

Group CEO & Founder

Founding Team

NOOR SALIH

PA TO CEO

Executive Team

Bionema Group Limited Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 16, 2.3x the trailing average.

  • Jun 19, 2026

    Monthly visitors increased 33% MoM, from 2.9K to 3.9K.

Bionema Group Limited Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bionema Group Limited Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bionema Group Limited's valuation, stock price, and market status.

Firmographic Details

HeadquartersSwansea
Employee Range10
Year Founded2012
Last FundingSep 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.